{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T03:57:27Z","timestamp":1774583847492,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010749","name":"Comiss\u00e3o Nacional de Energia Nuclear","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010749","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nitric Oxide"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.niox.2019.09.007","type":"journal-article","created":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T11:39:59Z","timestamp":1568806799000},"page":"25-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Nitric oxide-loaded chitosan nanoparticles as an innovative antileishmanial platform"],"prefix":"10.1016","volume":"93","author":[{"given":"Fernanda V.","family":"Cabral","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena T.","family":"Pelegrino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismael P.","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amedea B.","family":"Seabra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Cortez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha S.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.niox.2019.09.007_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004349","article-title":"A historical overview of the classification, evolution, and dispersion of Leishmania parasites and sandflies","volume":"10","author":"Akhoundi","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.niox.2019.09.007_bib2","series-title":"Global Health Observatory (GHO) Data","author":"World Health Organization (WHO)","year":"2019"},{"key":"10.1016\/j.niox.2019.09.007_bib3","author":"World Health Organization (WHO)"},{"key":"10.1016\/j.niox.2019.09.007_bib4","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1365-2230.2004.01605.x","article-title":"The psychological impact of cutaneous leishmaniasis","volume":"29","author":"Yanik","year":"2004","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.niox.2019.09.007_bib5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fcimb.2018.00222","article-title":"Biomarkers of cutaneous leishmaniasis","volume":"8","author":"Bahrami","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.niox.2019.09.007_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: a 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.niox.2019.09.007_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s40257-015-0114-z","article-title":"Cutaneous leishmaniasis: recent developments in diagnosis and management","volume":"16","author":"de Vries","year":"2015","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.niox.2019.09.007_bib8","doi-asserted-by":"crossref","first-page":"203818","DOI":"10.1155\/2012\/203818","article-title":"Reactive oxygen species and nitric oxide in cutaneous leishmaniasis","volume":"2012","author":"Horta","year":"2012","journal-title":"J. Parasitol. Res."},{"key":"10.1016\/j.niox.2019.09.007_bib9","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/375408a0","article-title":"Altered immune responses in mice lacking inducible nitric oxide synthase","volume":"375","author":"Wei","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.niox.2019.09.007_bib10","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1084\/jem.183.4.1501","article-title":"Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase","volume":"183","author":"Stenger","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.niox.2019.09.007_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1074-7613(00)80460-4","article-title":"Type 1 interferon (IFNalpha\/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite","volume":"8","author":"Diefenbach","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.niox.2019.09.007_bib12","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1128\/IAI.70.7.3727-3735.2002","article-title":"Nitric oxide-mediated proteasome-dependent oligonucleosomal DNA fragmentation in Leishmania amazonensis amastigotes","volume":"70","author":"Holzmuller","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.niox.2019.09.007_bib13","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1021\/acs.molpharmaceut.5b00248","article-title":"Encapsulation of N-diazeniumdiolates within liposomes for enhanced nitric oxide donor stability and delivery","volume":"12","author":"Suchyta","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.niox.2019.09.007_bib14","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/exd.13098","article-title":"Topical treatment with a two-component gel releasing nitric oxide cures C57BL\/6 mice from cutaneous leishmaniasis caused by Leishmania major","volume":"25","author":"Butsch","year":"2016","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.niox.2019.09.007_bib15","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1093\/jac\/dkt210","article-title":"S-nitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin lesions","volume":"68","author":"Costa","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.niox.2019.09.007_bib16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.niox.2006.01.011","article-title":"Leishmanicidal activity of primary S-nitrosothiols against Leishmania major and Leishmania amazonensis: implications for the treatment of cutaneous leishmaniasis","volume":"15","author":"de Souza","year":"2006","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.niox.2019.09.007_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.niox.2016.09.010","article-title":"Nitric oxide-releasing chitosan nanoparticles alleviate the effects of salt stress in maize plants","volume":"61","author":"Oliveira","year":"2016","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.niox.2019.09.007_bib18","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1517\/17425247.2014.885500","article-title":"Nanoparticles as multifunctional devices for the topical treatment of cutaneous leishmaniasis","volume":"11","author":"Moreno","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.niox.2019.09.007_bib19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/0883911516681329","article-title":"Chitosan-based silver nanoparticles: a study of the antibacterial, antileishmanial and cytotoxic effects - Dimensions","volume":"32","author":"Lima","year":"2017","journal-title":"J. Bioact. Compat Polym."},{"key":"10.1016\/j.niox.2019.09.007_bib20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijfoodmicro.2010.09.012","article-title":"Antimicrobial properties of chitosan and mode of action: a state of the art review","volume":"144","author":"Kong","year":"2010","journal-title":"Int. J. Food Microbiol."},{"key":"10.1016\/j.niox.2019.09.007_bib21","doi-asserted-by":"crossref","first-page":"E462","DOI":"10.3390\/polym10040462","article-title":"Biomedical applications of chitosan and its derivative nanoparticles","volume":"10","author":"Zhao","year":"2018","journal-title":"Polymers"},{"key":"10.1016\/j.niox.2019.09.007_bib22","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/1061186X.2018.1512112","article-title":"Chitosan-based nanoparticles as drug delivery systems: a review on two decades of research","volume":"27","author":"Naskar","year":"2019","journal-title":"J. Drug Target."},{"key":"10.1016\/j.niox.2019.09.007_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11051-017-3747-4","article-title":"Nitric oxide-releasing nanoparticles: synthesis, characterization, and cytotoxicity to tumorigenic cells","volume":"19","author":"Pelegrino","year":"2017","journal-title":"J. Nanoparticle Res."},{"key":"10.1016\/j.niox.2019.09.007_bib24","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1039\/C6MD00502K","article-title":"Chitosan nanoparticles for nitric oxide delivery in human skin","volume":"8","author":"Pelegrino","year":"2017","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.niox.2019.09.007_bib25","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/28\/6\/065101","article-title":"Development and evaluation of zinc phthalocyanine nanoemulsions for use in photodynamic therapy for Leishmania spp","volume":"28","author":"de Oliveira de Siqueira","year":"2017","journal-title":"Nanotechnology"},{"key":"10.1016\/j.niox.2019.09.007_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijpharm.2014.06.051","article-title":"Evaluation of antibacterial activity of nitric oxide-releasing polymeric particles against Staphylococcus aureus and Escherichia coli from bovine mastitis","volume":"473","author":"Cardozo","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.niox.2019.09.007_bib27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mimet.2013.02.007","article-title":"Parasite burden in Leishmania (Leishmania) amazonensis-infected mice: validation of luciferase as a quantitative tool","volume":"93","author":"Reimao","year":"2013","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.niox.2019.09.007_bib28","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.chom.2011.04.014","article-title":"Leishmania promotes its own virulence by inducing expression of the host immune inhibitory ligand CD200","volume":"9","author":"Cortez","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.niox.2019.09.007_bib29","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1128\/IAI.71.3.1225-1233.2003","article-title":"Nitric oxide partially controls coxiella burnetii phase II infection in mouse primary macrophages","volume":"71","author":"Zamboni","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.niox.2019.09.007_bib30","first-page":"68","article-title":"In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B","volume":"15","author":"Zauli-Nascimento","year":"2010","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.niox.2019.09.007_bib31","author":"De Vos"},{"key":"10.1016\/j.niox.2019.09.007_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.niox.2019.09.007_bib33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijpddr.2016.01.001","article-title":"Supplementation of host response by targeting nitric oxide to the macrophage cytosol is efficacious in the hamster model of visceral leishmaniasis and adds to efficacy of amphotericin B","volume":"6","author":"Pandya","year":"2016","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.niox.2019.09.007_bib34","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijantimicag.2017.01.033","article-title":"Targeting Leishmania amazonensis amastigotes through macrophage internalisation of a hydroxymethylnitrofurazone nanostructured polymeric system","volume":"50","author":"Monteiro","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.niox.2019.09.007_bib35","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.arcmed.2005.07.011","article-title":"Nitric oxide synthase (NOS) characterization in Leishmania amazonensis axenic amastigotes","volume":"37","author":"Genestra","year":"2006","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.niox.2019.09.007_bib36","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.biotechadv.2015.01.005","article-title":"State of the art, challenges and perspectives in the design of nitric oxide-releasing polymeric nanomaterials for biomedical applications","volume":"33","author":"Seabra","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.niox.2019.09.007_bib37","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1039\/C7NR08822A","article-title":"Antibacterial nitric oxide- and singlet oxygen-releasing polystyrene nanoparticles responsive to light and temperature triggers","volume":"10","author":"Dolansky","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.niox.2019.09.007_bib38","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/jbm.a.36349","article-title":"Nitric oxide-releasing antibacterial albumin plastic for biomedical applications","volume":"106","author":"Jones","year":"2018","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.niox.2019.09.007_bib39","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1021\/acsbiomaterials.9b00016","article-title":"Nitric oxide delivery using biocompatible perfluorocarbon microemulsion for antibacterial effect","volume":"5","author":"Choi","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.niox.2019.09.007_bib40","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.actbio.2017.12.005","article-title":"Nitric oxide-releasing injectable hydrogels with high antibacterial activity through in situ formation of peroxynitrite","volume":"67","author":"Hoang","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.niox.2019.09.007_bib41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cis.2018.11.008","article-title":"Pharmaceutical applications of chitosan","volume":"263","author":"Shariatinia","year":"2019","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.niox.2019.09.007_bib42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.molbiopara.2009.12.004","article-title":"Phospholipid and sphingolipid metabolism in Leishmania","volume":"170","author":"Zhang","year":"2010","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.niox.2019.09.007_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003000","article-title":"Leishmania amazonensis amastigotes highly express a tryparedoxin peroxidase isoform that increases parasite resistance to macrophage antimicrobial defenses and fosters parasite virulence","volume":"8","author":"Henard","year":"2014","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.niox.2019.09.007_bib44","doi-asserted-by":"crossref","DOI":"10.1088\/1742-6596\/617\/1\/012020","article-title":"Nitric oxide-releasing polymeric nanoparticles against Trypanosoma cruzi","volume":"617","author":"Seabra","year":"2015","journal-title":"J. Phys. Conf. Ser."},{"key":"10.1016\/j.niox.2019.09.007_bib45","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1006\/expr.1997.4205","article-title":"Leishmania spp.: mechanisms of toxicity of nitrogen oxidation products","volume":"87","author":"Mauel","year":"1997","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.niox.2019.09.007_bib46","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s13071-016-1540-3","article-title":"The site of the bite: Leishmania interaction with macrophages, neutrophils and the extracellular matrix in the dermis","volume":"9","author":"Menezes","year":"2016","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.niox.2019.09.007_bib47","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4161\/viru.20328","article-title":"The potential of nitric oxide releasing therapies as antimicrobial agents","author":"Schairer","year":"2012","journal-title":"Virulence"},{"key":"10.1016\/j.niox.2019.09.007_bib48","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.cbpa.2012.10.016","article-title":"Mechanisms of S-nitrosothiol formation and selectivity in nitric oxide signaling","volume":"16","author":"Smith","year":"2012","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.niox.2019.09.007_bib49","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1006\/expr.1997.4151","article-title":"Leishmania spp.: nitric oxide-mediated metabolic inhibition of promastigote and axenically grown amastigote forms","volume":"86","author":"Lemesre","year":"1997","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.niox.2019.09.007_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000179","article-title":"Control of parasitophorous vacuole expansion by LYST\/Beige restricts the intracellular growth of Leishmania amazonensis","volume":"4","author":"Wilson","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.niox.2019.09.007_bib51","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fimmu.2012.00058","article-title":"Subversion and utilization of host innate defense by Leishmania amazonensis","volume":"3","author":"Soong","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.niox.2019.09.007_bib52","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ijpara.2007.04.007","article-title":"The amastigote forms of Leishmania are experts at exploiting host cell processes to establish infection and persist","volume":"37","author":"Kima","year":"2007","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.niox.2019.09.007_bib53","doi-asserted-by":"crossref","first-page":"e905","DOI":"10.1371\/journal.pntd.0000905","article-title":"Fusion between Leishmania amazonensis and Leishmania major parasitophorous vacuoles: live imaging of coinfected macrophages","volume":"4","author":"Real","year":"2010","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.niox.2019.09.007_bib54","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jddst.2017.10.016","article-title":"S-nitrosoglutathione-containing chitosan nanoparticles dispersed in Pluronic F-127 hydrogel: potential uses in topical applications","volume":"43","author":"Pelegrino","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."}],"container-title":["Nitric Oxide"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860319301090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860319301090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:04:11Z","timestamp":1761069851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089860319301090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":54,"alternative-id":["S1089860319301090"],"URL":"https:\/\/doi.org\/10.1016\/j.niox.2019.09.007","relation":{},"ISSN":["1089-8603"],"issn-type":[{"value":"1089-8603","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitric oxide-loaded chitosan nanoparticles as an innovative antileishmanial platform","name":"articletitle","label":"Article Title"},{"value":"Nitric Oxide","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.niox.2019.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}